Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

Medtronic (NYSE: MDT) says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension.

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...

While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...

Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device. The ...

The supplement market is constantly evolving, with new products appearing regularly, each promising to be the solution to a specific health concern. One such product that has recently caught attention ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 ...

We are aware of reports regarding supply issues of insulin in the UK. Here’s the latest information on how your treatment may be impacted.

The participants were randomized either to treatment A, insulin pump Minimed 640G and independent iscCGM (Freestyle ... Author OC was employed by the company Medtronic. Author CB got speakers ...

The t:slim X2 insulin pump with Control-IQ technology is the #1-rated automated insulin delivery (AID) system 1, and now the first and only insulin pump in Canada that is integrated with both ...